Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elsmarieke van de Giessen

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2010
The SPECT tracer [123I]ADAM binds selectively to serotonin transporters: a double-blind, placebo-controlled study in healthy young menElsmarieke van de Giessen, Jan Booij
European Journal of Nuclear Medicine and Molecular Imaging|October 25, 2012
Comments on Eusebio et al.: Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjectsJan Booij, Elsmarieke van de Giessen, Swen Hesse, et al.
European Journal of Radiology|May 18, 2021
Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imagingLiesbeth Reneman, Marieke van der Pluijm, Anouk Schrantee, et al.
Neuroscience Applied|March 11, 2026
The potential of neuromelanin-sensitive MRI in psychiatric disordersEline Neutelings, Elsmarieke van de Giessen, Lieuwe de Haan, et al.
Biological Psychiatry|January 27, 2009
Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjectsAnissa Abi-Dargham, Elsmarieke van de Giessen, Mark Slifstein, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 15, 2022
α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New PerspectivesObada M Alzghool, Guus van Dongen, Elsmarieke van de Giessen, et al.
Journal of Psychopharmacology (Oxford, England)|May 3, 2014
Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesityElsmarieke van de Giessen, Funda Celik, Dave H Schweitzer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 6, 2011
Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese ratsElsmarieke van de Giessen, Kora de Bruin, Susanne E la Fleur, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 25, 2024
Survey among experts on the future role of tau-PET in clinical practice and trialsMarie R Vermeiren, Ismael L Calandri, Wiesje M van der Flier, et al.
Obesity (Silver Spring, Md.)|February 7, 2012
Free-choice and no-choice high-fat diets affect striatal dopamine D2/3 receptor availability, caloric intake, and adiposityElsmarieke van de Giessen, Susanne E la Fleur, Kora de Bruin, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2010
The SPECT tracer [123I]ADAM binds selectively to serotonin transporters: a double-blind, placebo-controlled study in healthy young menElsmarieke van de Giessen, Jan Booij
European Journal of Nuclear Medicine and Molecular Imaging|October 25, 2012
Comments on Eusebio et al.: Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjectsJan Booij, Elsmarieke van de Giessen, Swen Hesse, et al.
European Journal of Radiology|May 18, 2021
Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imagingLiesbeth Reneman, Marieke van der Pluijm, Anouk Schrantee, et al.
Neuroscience Applied|March 11, 2026
The potential of neuromelanin-sensitive MRI in psychiatric disordersEline Neutelings, Elsmarieke van de Giessen, Lieuwe de Haan, et al.
Biological Psychiatry|January 27, 2009
Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjectsAnissa Abi-Dargham, Elsmarieke van de Giessen, Mark Slifstein, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 15, 2022
α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New PerspectivesObada M Alzghool, Guus van Dongen, Elsmarieke van de Giessen, et al.
Journal of Psychopharmacology (Oxford, England)|May 3, 2014
Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesityElsmarieke van de Giessen, Funda Celik, Dave H Schweitzer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 6, 2011
Triple monoamine inhibitor tesofensine decreases food intake, body weight, and striatal dopamine D2/D3 receptor availability in diet-induced obese ratsElsmarieke van de Giessen, Kora de Bruin, Susanne E la Fleur, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 25, 2024
Survey among experts on the future role of tau-PET in clinical practice and trialsMarie R Vermeiren, Ismael L Calandri, Wiesje M van der Flier, et al.
Obesity (Silver Spring, Md.)|February 7, 2012
Free-choice and no-choice high-fat diets affect striatal dopamine D2/3 receptor availability, caloric intake, and adiposityElsmarieke van de Giessen, Susanne E la Fleur, Kora de Bruin, et al.
Pageof 12